Expanded Access Program, also known as an Expanded Access Protocol, refers to inclusion of patients in a clinical trial, but outside the clinical trial setting, when it is clear that additional patients may benefit from the treatment
This disambiguation page lists articles associated with the same title.
If an internal link led you here, you may wish to change the link to point directly to the intended article.